As cancer care professionals who experience the challenges of providing quality cancer care first-hand, NMSCO members are well positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology. State and federal legislation can have a significant impact on the financial viability of local cancer programs, which is why it's so important that our members make their voices heard.
We want to hear from you! If there is a specific piece of legislation you want to know more about, an important resource we're missing, or if you want to get more involved, please contact us!
House Judiciary Passes NM HB 129: Pharmacy Benefit Manager Reporting
The New Mexico Society of Clinical Oncology (NMSCO) is pleased to announce the passing of HB 129: Pharmacy Benefit Manager Reporting.
We appreciate and thank the oncology community and NMSCO President Barbara McAneny, MD, FACP, FASCO, New Mexico Oncology Hematology Consultants, Ltd., for testifying and supporting this critical piece of legislation.
NMSCO and ASCO Supported PBM/Co-Pay Accumulator Bill Passes New Mexico Senate Committee
The New Mexico Society of Clinical Oncology (NMSCO) and Association for Clinical Oncology (ASCO) collaborated on a joint support letter for HB 129: Pharmacy Benefit Manager Reporting, which would require pharmacy benefit managers to report aggregate rebate data to the Office of the Superintendent of Insurance and pass the savings they receive from rebates on to the patient. Read support letter.
New Mexico Department of Health
New Mexico Legislature
Find Your Federal Representative
Office of the Governor
Oncology State Societies at ACCC: Snapshot from the 2022 ASCO Annual Meeting
In this clip, Stephanie Van Winkle, Executive Director of the Oncology State Societies at ACCC, gives an overview of the important work the Oncology State Societies does to empower its members around state and federal advocacy issues, and help them support cancer care delivery in their state. Join today!